CClinicalTrials.gg
Sign In
RecruitingNCT06858345CARDIAC-OATUpdated Mar 5, 2025

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

An observational study in Preeclampsia, sponsored by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. Recruiting at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-05.

Sponsored by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
Female
01

Study summary

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.

02

Conditions studied

  • Preeclampsia

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Pregnant patients undergoing regular hospital follow-up

Inclusion criteria

  • Age greater than or equal to 18 years
  • Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy.

Exclusion criteria

Exclusion Criteria:

  • Minors under 18 years of age.
  • Women with mental disabilities.
  • Major congenital fetal anomaly.
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
50 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • • Duration of gestation in pregnancy complicated by hypertensive state of pregnancy with antihyperte

    • Duration of gestation in pregnancy complicated by hypertensive state of pregnancy with antihypertensive therapy guided by hemodynamic phenotypes

05

What researchers measure

Primary outcomes

  1. Prolongation of at least one week of gestation in pregnancy complicated by hypertensive state of pregnancy with antihypertensive therapy guided by hemodynamic phenotypes

    Number of weeks of pregnancy

    Time frame: Up to 40 weeks

06

Study locations

1 of 1 sites recruiting
  • HCUVA
    El Palmar, Murcia 30120, Spain
    Recruiting
07

Registry details

Key details

Study ID
NCT06858345
Lead sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Responsible party
Sponsor
First posted
Mar 5, 2025
Start date
Jan 1, 2025
Primary completion
Jan 15, 2026 (estimated)
Completion
Jan 15, 2026 (estimated)
Last update
Mar 5, 2025

Study contacts

Catalina de Paco Matallana, MD
Contact
katy.depaco@gmail.com
968369500

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pre-Eclampsia→

Other studies from this sponsor

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Start the discussion